Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingao Li

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Translational Oncology|August 8, 2021
Effects of locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world studyFujuan Zeng, Tianzhu Lu, Fei Xie, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 27, 2025
MRPL21-PARP1 axis promotes cisplatin resistance in head and neck squamous cell carcinoma by inhibiting autophagy through the PI3K/AKT/mTOR signaling pathwayRui Guan, Ce Li, Ruijie Jiao, et al.
International Journal of Cancer|February 24, 2025
Efficacy and optimal duration of maintenance immunotherapy following systemic chemoimmunotherapy and locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A multicenter retrospective cohort studyYujun Hu, Tianzhu Lu, Hao Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 19, 2023
Constructing an individualized surveillance framework for nasopharyngeal carcinoma based on a dynamic risk-adapted approachTianzhu Lu, Hanchuan Xu, Wanfang Huang, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 19, 2016
Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinomaRamesh Paudyal, Jung Hun Oh, Nadeem Riaz, et al.
Oncotarget|October 22, 2016
Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinomaJingjing Yu, Yuling Huang, Lijuan Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 6, 2024
Selectively sparing of the supraclavicular area during intensity-modulated radiotherapy in nasopharyngeal carcinoma: A double-center observation studyQiaojuan Guo, Tianzhu Lu, Wanfang Huang, et al.
Cancer|December 7, 2018
A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinomaChunling Jiang, Huan Wang, Chaofei Xia, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2025
Validation and development of a refined M1 category for nasopharyngeal carcinoma based on the version-nine of AJCC/UICC TNM staging system in the immunotherapy era: A multicenter cohort studyHanchuan Xu, Yujun Hu, Tao Xie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 12, 2025
Reducing radiation-induced hypothyroidism by modified delineation of cervical lymphatic drainage area for nasopharyngeal carcinoma treated by intensity-modulated radiation Therapy: 3 years' experienceTianzhu Lu, Xiying Gao, Zhongren Yu, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Translational Oncology|August 8, 2021
Effects of locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world studyFujuan Zeng, Tianzhu Lu, Fei Xie, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 27, 2025
MRPL21-PARP1 axis promotes cisplatin resistance in head and neck squamous cell carcinoma by inhibiting autophagy through the PI3K/AKT/mTOR signaling pathwayRui Guan, Ce Li, Ruijie Jiao, et al.
International Journal of Cancer|February 24, 2025
Efficacy and optimal duration of maintenance immunotherapy following systemic chemoimmunotherapy and locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A multicenter retrospective cohort studyYujun Hu, Tianzhu Lu, Hao Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 19, 2023
Constructing an individualized surveillance framework for nasopharyngeal carcinoma based on a dynamic risk-adapted approachTianzhu Lu, Hanchuan Xu, Wanfang Huang, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 19, 2016
Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinomaRamesh Paudyal, Jung Hun Oh, Nadeem Riaz, et al.
Oncotarget|October 22, 2016
Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinomaJingjing Yu, Yuling Huang, Lijuan Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 6, 2024
Selectively sparing of the supraclavicular area during intensity-modulated radiotherapy in nasopharyngeal carcinoma: A double-center observation studyQiaojuan Guo, Tianzhu Lu, Wanfang Huang, et al.
Cancer|December 7, 2018
A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinomaChunling Jiang, Huan Wang, Chaofei Xia, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2025
Validation and development of a refined M1 category for nasopharyngeal carcinoma based on the version-nine of AJCC/UICC TNM staging system in the immunotherapy era: A multicenter cohort studyHanchuan Xu, Yujun Hu, Tao Xie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 12, 2025
Reducing radiation-induced hypothyroidism by modified delineation of cervical lymphatic drainage area for nasopharyngeal carcinoma treated by intensity-modulated radiation Therapy: 3 years' experienceTianzhu Lu, Xiying Gao, Zhongren Yu, et al.
Pageof 8